Promising clinical studies surrounding Retatrutide , specifically the 120 milligram formulation referred to as ZPHC, suggest a impressive benefit on body mass reduction and related metabolic illnesses . Scientists believe that this innovative compound, influencing both GLP-1 and GIP receptors ,